We dont require coaching. HR leader at large manufacturer What might the future hold for obesity drug coverage
GLP-1 receptor agonists act primarily by enhancing postprandial insulin secretion and suppressing glucagon release, leading to improved glycemic control (8)
Many patients avoid GLP-1s mainly because of injections, so an oral option is great news
Clients in more than 60 countries rely on us for reliable service, technical excellence, and long-term collaboration
At the same time, multiple blockbuster GLP-1 therapies are already on the market (Ozempic, Wegovy, and Mounjaro), with numerous next-generation analogues and combination incretin therapies currently in development
Sustancias como la inulina, los beta-glucanos y el almidn resistente actan como prebiticos, alimentando las bacterias intestinales beneficiosas